Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lauxera Capital Partners

Investor type Private Equity Firm
Founders Alex Slack Samuel Levy

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$50M
Portfolio companies 5
Rounds per year 3.00
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon
Stages of investment
Late Stage Venture

Areas of investment

  • Medical Device
  • Health Care
  • Biotechnology
  • Information Technology
  • Health Insurance

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lauxera Capital Partners:
Typical Co-investors
Lauxera Capital Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lauxera Capital Partners:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Arab Bank (Switzerland) Geneva, Geneve, Switzerland
BIG BETS -
BioSciKin -
Blue Scorpion Investments New York, New York, United States
Canadian Western Bank Alberta, Canada, Edmonton
Coghill Capital Management Chicago, Illinois, United States
Coris Bank International Burkina Faso, Kadiogo, Ouagadougou
Dark Horse Investment China, Hong Kong, Hong Kong Island
Dentsu Ventures Chiyoda, Japan
DPE Deutsche Private Equity Bayern, Germany, Munich
Elevance Renewable Sciences Illinois, United States, Woodridge
Jiang Wei Guquan Touzi (Shanghai) Co., Ltd. China, Shanghai
MergeLane Boulder, Colorado, United States
Monex Precious Metals California, Newport Beach, United States
Parallel Atlanta, Georgia, United States
SWL Healthcare Ventures -
Talkot Capital California, Sausalito, United States
Trend Investment Group -
WidInvest AG Switzerland, Zug, Zug
Zuiyou Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Veranex

Health Diagnostics
Information Services
Medical Device
18 May 2022 Raleigh, North Carolina, United States

Lifen

Computer
Health Care
$59M15 Nov 2021 Paris, Ile-de-France, France

Caresyntax

Analytics
Artificial Intelligence
Data Visualization
Health Care
Health Insurance
Hospital
Information Technology
Machine Learning
Medical
Software
$30M16 Sep 2021 Boston, Massachusetts, United States

Caresyntax

Health Care
Health Insurance
Hospital
Information Technology
Machine Learning
Medical
Software
$100M28 Apr 2021 Boston, Massachusetts, United States

LUMICKS

Biotechnology
Life Science
Medical Device
$91M16 Apr 2021 Amsterdam, North Holland, Netherlands

Reapplix

Biotechnology
Medical Device
Therapeutics
$24M13 Jul 2020 Denmark, Capital Region of Denmark, Denmark

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lauxera Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: